284 related articles for article (PubMed ID: 21974913)
1. Visual field progression outcomes in glaucoma subtypes.
De Moraes CG; Liebmann JM; Liebmann CA; Susanna R; Tello C; Ritch R
Acta Ophthalmol; 2013 May; 91(3):288-93. PubMed ID: 21974913
[TBL] [Abstract][Full Text] [Related]
2. Optic disc progression and rates of visual field change in treated glaucoma.
De Moraes CG; Liebmann JM; Park SC; Teng CC; Nemiroff J; Tello C; Ritch R
Acta Ophthalmol; 2013 Mar; 91(2):e86-91. PubMed ID: 23356423
[TBL] [Abstract][Full Text] [Related]
3. The region of largest β-zone parapapillary atrophy area predicts the location of most rapid visual field progression.
Teng CC; De Moraes CG; Prata TS; Liebmann CA; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2011 Dec; 118(12):2409-13. PubMed ID: 21885127
[TBL] [Abstract][Full Text] [Related]
4. Effect of successful and partly successful filtering surgery on the velocity of glaucomatous visual field progression.
Folgar FA; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
J Glaucoma; 2012 Dec; 21(9):615-8. PubMed ID: 21623221
[TBL] [Abstract][Full Text] [Related]
5. Beta-Zone parapapillary atrophy and the velocity of glaucoma progression.
Teng CC; De Moraes CG; Prata TS; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 May; 117(5):909-15. PubMed ID: 20132988
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.
Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM
Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for visual field progression in treated glaucoma.
De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
[TBL] [Abstract][Full Text] [Related]
10. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma.
Ahrlich KG; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1458-63. PubMed ID: 20042657
[TBL] [Abstract][Full Text] [Related]
11. Glaucoma surgery decreases the rates of localized and global visual field progression.
Folgar FA; de Moraes CG; Prata TS; Teng CC; Tello C; Ritch R; Liebmann JM
Am J Ophthalmol; 2010 Feb; 149(2):258-264.e2. PubMed ID: 20103054
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
[TBL] [Abstract][Full Text] [Related]
13. Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma.
Rao HL; Kumar AU; Babu JG; Senthil S; Garudadri CS
Ophthalmology; 2011 Feb; 118(2):249-53. PubMed ID: 20728941
[TBL] [Abstract][Full Text] [Related]
14. Lower corneal hysteresis is associated with more rapid glaucomatous visual field progression.
De Moraes CV; Hill V; Tello C; Liebmann JM; Ritch R
J Glaucoma; 2012; 21(4):209-13. PubMed ID: 21654511
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
[TBL] [Abstract][Full Text] [Related]
16. Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma.
Choi J; Lee JR; Lee Y; Lee KS; Na JH; Han S; Kook MS
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6150-7. PubMed ID: 23963166
[TBL] [Abstract][Full Text] [Related]
17. Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis.
Park SC; Kung Y; Su D; Simonson JL; Furlanetto RL; Liebmann JM; Ritch R
Ophthalmology; 2013 Aug; 120(8):1546-50. PubMed ID: 23697959
[TBL] [Abstract][Full Text] [Related]
18. Is Myopic Optic Disc Appearance a Risk Factor for Rapid Progression in Medically Treated Glaucomatous Eyes With Confirmed Visual Field Progression?
Lee JR; Kim S; Lee JY; Back S; Lee KS; Kook MS
J Glaucoma; 2016 Mar; 25(3):330-7. PubMed ID: 25580889
[TBL] [Abstract][Full Text] [Related]
19. Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction.
Park HY; Park SH; Park CK
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2557-63. PubMed ID: 24692126
[TBL] [Abstract][Full Text] [Related]
20. Progression detection capability of macular thickness in advanced glaucomatous eyes.
Sung KR; Sun JH; Na JH; Lee JY; Lee Y
Ophthalmology; 2012 Feb; 119(2):308-13. PubMed ID: 22182800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
